NWAG
KRYS icon

Net Worth Advisory Group’s Krystal Biotech KRYS Stock Holding History

Net Worth Advisory Group’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$449K Sell
1,207
-100
-8% -$29.9K 0.11% 193
2026
Q1 		$338K Buy
1,307
+384
+42% +$102K 0.07% 272
2025
Q4 		$228K Buy
+923
New +$194K 0.05% 403

Other funds holding KRYS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
CPIA
Cornell Pochily Investment Advisors Ithaca, New York $372M AUM 29.32% 1-Year Est. Return

Net Worth Advisory Group's KRYS Position: Q2 2026 in Review

Net Worth Advisory Group reduced its Krystal Biotech (KRYS) stake by 7.7% in Q2 2026, selling an estimated $29.9K and leaving 1,207 shares worth $449K. The position accounts for 0.11% of the portfolio, ranked #193.

Net Worth Advisory Group first reported a position in KRYS in Q4 2025 and has held it in 3 quarters since. 44 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Net Worth Advisory Group held 1,207 shares of Krystal Biotech worth $449K as of Q2 2026.
  • Net Worth Advisory Group sold 100 Krystal Biotech shares in Q2 2026, an estimated $29.9K.
  • Krystal Biotech made up 0.11% of Net Worth Advisory Group's portfolio in Q2 2026, its #193 holding.
  • Net Worth Advisory Group first reported a position in Krystal Biotech in Q4 2025 and has held it in 3 quarters since.
  • 44 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Net Worth Advisory Group's 13F filing for Q2 2026, filed 14 Jul 2026.